Full Press Release Details
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced that management will participate in the following investor conferences: 9th Annual Evercore Healthcare Conference: Scholar Rock is scheduled to participate in a fireside chat at 8:45 a.m. ET on Tuesday, December 1, 2026